These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7641504)

  • 21. Multiple brown tumors: a bone complication due to long-term untreated pseudohypoparathyroidism.
    Gonnelli S; Briot K; Cormier C; Teboul S; Roux C; Koumakis E
    Osteoporos Int; 2024 Jan; 35(1):195-199. PubMed ID: 37644196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
    Mizunashi K; Furukawa Y; Miura R; Yumita S; Sohn HE; Yoshinaga K
    J Clin Invest; 1988 Sep; 82(3):861-5. PubMed ID: 2843573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.
    Andress DL; Norris KC; Coburn JW; Slatopolsky EA; Sherrard DJ
    N Engl J Med; 1989 Aug; 321(5):274-9. PubMed ID: 2631697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of hypocalcemia caused by hypoparathyroidism or pseudohypoparathyroidism with domestic-made calcitriol: a prospective and self-controlled clinical trial.
    Wang O; Xing XP; Meng XW; Xia WB; Li M; Jiang Y; Hu YY; Liu HC
    Chin Med J (Engl); 2009 Feb; 122(3):279-83. PubMed ID: 19236804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of 1,25-dihydroxyvitamin D production by parathyroid hormone and dibutyryl 3',5'-cyclic AMP in normal subjects, hypoparathyroidism and pseudohypoparathyroidism.
    Unakami H; Furukawa Y; Sohn HE; Yumita S; Miura R; Hanew K; Yoshinaga K
    Tohoku J Exp Med; 1982 Oct; 138(2):167-75. PubMed ID: 6294914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part IV of IV parts: The state of the bones in uremic hyperaparathyroidism--the mechanisms of skeletal resistance to PTH in renal failure and pseudohypoparathyroidism and the role of PTH in osteoporosis, osteopetrosis, and osteofluorosis.
    Parfitt AM
    Metabolism; 1976 Oct; 25(10):1157-88. PubMed ID: 787723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
    Voigts AL; Felsenfeld AJ; Llach F
    Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
    Stögmann W
    Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D metabolism during recovery from severe osteitis fibrosa cystica of primary hyperparathyroidism.
    Gonzalez-Villapando C; Porath A; Berelowitz M; Marshall L; Favus MJ
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1180-3. PubMed ID: 6893459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.
    Goodman WG; Ramirez JA; Belin TR; Chon Y; Gales B; Segre GV; Salusky IB
    Kidney Int; 1994 Oct; 46(4):1160-6. PubMed ID: 7861712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent hyperparathyroidism due to parathyroid carcinoma.
    Ellis HA; Floyd M; Herbert FK
    J Clin Pathol; 1971 Oct; 24(7):596-604. PubMed ID: 4107487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of plasma 1,25-dihydroxyvitamin D in the human PTH(1-34) infusion test: an improved index for the diagnosis of idiopathic hypoparathyroidism and pseudohypoparathyroidism.
    Miura R; Yumita S; Yoshinaga K; Furukawa Y
    Calcif Tissue Int; 1990 May; 46(5):309-13. PubMed ID: 2159833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1 alpha,25-dihydroxyvitamin D3 corrects osteomalacia in hypoparathyroidism and pseudohypoparathyroidism.
    Epstein S; Meunier PJ; Lambert PW; Stern PH; Bell NH
    Acta Endocrinol (Copenh); 1983 Jun; 103(2):241-7. PubMed ID: 6687971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of response of 1,25-dihydroxycholecalciferol to exogenous parathyroid hormone in a patient with treated pseudohypoparathyroidism.
    Braun JJ; Birkenhäger JC; Visser TJ; Juttmann JR
    Clin Endocrinol (Oxf); 1981 Apr; 14(4):403-7. PubMed ID: 6266703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The development of pseudohypoparathyroidism. Involvement of progressively increasing serum parathyroid hormone concentrations, increased 1,25-dihydroxyvitamin D concentrations, and 'migratory' subcutaneous calcifications.
    Tsang RC; Venkataraman P; Ho M; Steichen JJ; Whitsett J; Greer F
    Am J Dis Child; 1984 Jul; 138(7):654-8. PubMed ID: 6328970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
    Fournier A; Oprisiu R; Hottelart C; Yverneau PH; Ghazali A; Atik A; Hedri H; Said S; Sechet A; Rasolombololona M; Abighanem O; Sarraj A; El Esper N; Moriniere P; Boudailliez B; Westeel PF; Achard JM; Pruna A
    Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serial changes in bone mineral density and bone turnover after correction of secondary hyperparathyroidism in a patient with pseudohypoparathyroidism type Ib.
    Tollin SR; Perlmutter S; Aloia JF
    J Bone Miner Res; 2000 Jul; 15(7):1412-6. PubMed ID: 10893692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of parathyroid hormone on 1,25-dihydroxyvitamin D formation in type I pseudohypoparathyroidism.
    Aksnes L; Aarskog D
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1223-6. PubMed ID: 6255001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism.
    Malberti F; Corradi B; Cosci P; Calliada F; Marcelli D; Imbasciati E
    Am J Kidney Dis; 1996 Nov; 28(5):704-12. PubMed ID: 9158208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.